Observational (n=970)
Yes
The G12P[8] rotavirus genotype emerged as a dominant strain in Brazil in 2014, affecting both children and adults, highlighting the need for ongoing surveillance to monitor vaccine efficacy.
Answers are grounded in this paper and cite their sources.
G12P[8] emergence across ages in Brazil warrants ongoing strain surveillance; leaves open vaccine efficacy against dominant genotypes in adults and children.
Group A rotavirus (RVA) genotype G12 is habitually associated with diarrhea disease (DD) in African children and recently its detection has increased worldwide. A total of 970 stool samples collected from individuals with DD in the Northeastern, Southeastern, and Southern Brazilian regions, Eastern coast, were analyzed and 321 (33%) were positive for RVA and of these, 241 (75%) genotyped as G12P[8]. The rate of RVA positivity was higher among children aged 5-10 years old (60%). All RVA infections observed in adults aged >21 years were G12P[8] (n = 27) showing that this genotype affected older age groups during the year of 2014 in Brazil. Phylogenetic analysis of VP7 and VP8* G12P[8] strains demonstrated an elevated similarity among Brazilian and G12-III prototypes strains circulating worldwide recently, suggesting that this lineage is associated with the global spread of the G12 genotype, considered as the 6th most prevalent human RVA genotype nowadays; while other G12 lineages remain sporadically detected and usually detected in association with other P genotypes. VP8* analysis revealed that Brazilian strains belong to P[8]-3 lineage, the single P[8] lineage presently detected in the country. No major nucleotide/amino acid disparities were observed among strains recovered from children and adults for VP7 and VP8* genes. These data are essential to support the surveillance studies, particularly in countries where the RVA vaccine was introduced in their National Immunization Program enabling identification of potential alterations in the epidemiological profile that can impact its efficacy in vaccination programs. J. Med. Virol. 89:64-70, 2017.
No takes yet. Share an insight, caveat, or question.
Silva‐Sales et al. (2016) conducted an observational in Diarrhea disease (n=970). Group A rotavirus (RVA) genotype G12P[8] was evaluated on RVA positivity and G12P[8] genotype prevalence.
Synapse has enriched 10 related papers. Consider them for comparative context: